BioSenic S.A. (BIOS.BR)

EUR 0.0

(0.0%)

Operating Income Summary of BioSenic S.A.

BioSenic S.A.'s latest annual operating income in 2023 was -7.04 Million EUR , down -203.71% from previous year.
BioSenic S.A.'s latest quarterly operating income in 2024 Q2 was -233.5 Thousand EUR , down 0.0% from previous quarter.
BioSenic S.A. reported an annual operating income of -2.31 Million EUR in 2022, up 80.73% from previous year.
BioSenic S.A. reported an annual operating income of -12.02 Million EUR in 2021, up 19.92% from previous year.
BioSenic S.A. reported a quarterly operating income of -233.5 Thousand EUR for 2024 Q1, up 85.13% from previous quarter.
BioSenic S.A. reported a quarterly operating income of -7.58 Million EUR for 2023 FY, down -227.09% from previous quarter.

Annual Operating Income Chart of BioSenic S.A. (2023 - 2012)

Historical Annual Operating Income of BioSenic S.A. (2023 - 2012)

Year	Operating Income	Operating Income Growth
2023	-7.04 Million EUR	-203.71%
2022	-2.31 Million EUR	80.73%
2021	-12.02 Million EUR	19.92%
2020	-15.01 Million EUR	-34.39%
2019	-11.17 Million EUR	2.55%
2018	-11.46 Million EUR	6.73%
2017	-12.29 Million EUR	3.95%
2016	-12.79 Million EUR	-4.7%
2015	-12.22 Million EUR	-117.28%
2014	-5.62 Million EUR	-39.15%
2013	-4.04 Million EUR	-10.4%
2012	-3.66 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-233.5 Thousand EUR	0.0%
2024 Q1	-233.5 Thousand EUR	85.13%
2023 FY	-7.58 Million EUR	-227.09%
2023 Q1	-1.95 Million EUR	-112.01%
2023 Q2	-4.26 Million EUR	-118.71%
2023 Q3	-1.56 Million EUR	63.22%
2023 Q4	-1.57 Million EUR	-0.06%
2022 Q4	-920 Thousand EUR	0.0%
2022 FY	-2.31 Million EUR	80.73%
2022 Q3	-920 Thousand EUR	78.88%
2022 Q2	-4.35 Million EUR	0.0%
2021 Q4	-7.27 Million EUR	0.0%
2021 FY	-12.02 Million EUR	19.92%
2021 Q2	-6.49 Million EUR	0.0%
2020 Q4	-7.54 Million EUR	0.0%
2020 FY	-15.01 Million EUR	-34.39%
2020 Q2	-10.13 Million EUR	0.0%
2019 FY	-11.17 Million EUR	2.55%
2019 Q2	-7.11 Million EUR	0.0%
2019 Q4	-7.38 Million EUR	0.0%
2018 Q4	-7.58 Million EUR	0.0%
2018 FY	-11.46 Million EUR	6.73%
2017 FY	-12.29 Million EUR	3.95%
2016 FY	-12.79 Million EUR	-4.7%
2015 FY	-12.22 Million EUR	-117.28%
2014 Q3	-1.08 Million EUR	0.0%
2014 FY	-5.62 Million EUR	-39.15%
2014 Q4	-1.88 Million EUR	-74.35%
2013 Q4	-1.31 Million EUR	0.0%
2013 FY	-4.04 Million EUR	-10.4%
2012 FY	-3.66 Million EUR	0.0%

Peer Operating Income Comparison of BioSenic S.A.

Name	Operating Income	Operating Income Difference
Nicox S.A.	-17.5 Million EUR	59.778%
European Medical Solutions	-135 Thousand EUR	-5114.815%
FERMENTALG	-11.8 Million EUR	40.379%
argenx SE	-417.15 Million EUR	98.312%
Celyad Oncology SA	-8.45 Million EUR	16.755%
Hyloris Pharmaceuticals SA	-15.99 Million EUR	55.981%
Onward Medical N.V.	-35.46 Million EUR	80.148%
Oxurion NV	-12.11 Million EUR	41.866%
PHAXIAM Therapeutics S.A.	-23.66 Million EUR	70.245%
Financière de Tubize SA	-2.14 Million EUR	-228.362%
UCB SA	604 Million EUR	101.166%